Uncategorized

By Aaron Conley Lisa Monteggia, Ph.D. Barlow Family Director of the Vanderbilt Brain Institute and acclaimed neuroscientist Lisa Monteggia was named incoming co-principal editor, along with Dr. Tony George from the University of Toronto, of the journal Neuropsychopharmacology. Their appointments begin… Read More

By Dave Cortez and Aaron Conley The Department of Biochemistry at Vanderbilt University School of Medicine Basic Sciences announced new annual awards for postdoctoral scholars called the Destination Biochemistry Postdoctoral Scholar Awards. These awards will support exceptional postdoctoral fellows from around the world as they join labs in the Department… Read More

By Wendy Bindeman Welcome to the first of four articles in our new “Meet the Departments” series! The Vanderbilt University School of Medicine Basic Sciences is composed of four departments: Biochemistry, Cell and Developmental Biology, Molecular Physiology and Biophysics, and Pharmacology. Through this article series, we… Read More

By Mariana Byndloss If I could define Zach in one word, it would be LIGHT. Zach brought LIGHT to the world around him with his kindness, open mind and his way of accepting others and always seeing the good in people. And the funniest thing about it is that… Read More

By Wendy Bindeman Vanderbilt School of Medicine Basic Sciences is excited to welcome the incoming leadership team for the Initiative for Maximizing Student Diversity. IMSD recruits and supports biomedical trainees from backgrounds underrepresented in science during their graduate careers. The program was founded in 1998 by Roger Chalkley, formerly senior… Read More

A Vanderbilt University Medical Center licensee, Evotec SE, announced on January 28, 2020 that EVT894, a monoclonal antibody to treat and potentially prevent chikungunya virus infections, has entered clinical development. The Phase I, randomised, double-blind, single centre, single dose escalation study to evaluate the safety, pharmacokinetics, and immunogenicity of EVT894 vs… Read More

REQUEST FOR APPLICATIONS Rare Genetic Diseases Opening January 2021 Rolling Submission-Review Ancora Innovations is a collaboration between Vanderbilt University and Deerfield Management, focused on the union of Vanderbilt’s innovative life science discovery efforts and Deerfield’s commitment to accelerating state-of-the-art drug development. Deerfield will fund Ancora Innovation with up to $65… Read More

By Alexandra Fuller By the time March rolls around, New Year’s resolutions to ditch the expensive lattes and spend less time (and money) shopping online are often far behind us. Activity within the nucleus accumbens, a region of the brain implicated in motivation and addiction, may be at play. Read More

By Naotoshi Nakamura Dr. Nakamura, a Specially Appointed Associate Professor at the Center for Mathematical Modeling and Data Science, Osaka University, was a visiting scholar in the Vito Quaranta lab and has since become a long-distance participant in discussions and lab meetings. Nakamura has also been appointed as… Read More

By Sara Eaton There are biological differences in how male and female mice respond to different cues in their environment. Deciphering those differences can help researchers develop drugs that work equally well in both human sexes. New research from the labs of Erin Calipari and Cody Siciliano, both… Read More